CALL FOR PROPOSALS 2022 HSCI JUNIOR FACULTY PROGRAM
AWARD AMOUNT $600,000 per year to include three or four subprojects of $150,00-$200,000 for up to three years
DEADLINE FOR APPLICATION Friday, August 5, 2022
ANTICIPATED AWARD DATE Tuesday, November 1, 2022
The Harvard Stem Cell Institute (HSCI) invites applications for a new project to be funded through the Junior Faculty Program. The specific purpose of the 2022 call for funding is to identify an innovative collaborative project by junior faculty. Proposed collaborations can represent either basic, translational, or clinical science, and can span multiple disease areas. This funding is meant to support novel, high-impact, and cross-cutting research that could lead to new treatments and/or fundamentally enhance our understanding of the target disease area(s) and/or organ systems. The collaborative project should include a plan for the regular interaction of group members and coordination of research activities carried out in multiple research laboratories.... Read more about HSCI invites applications for Junior Faculty Programs
Since their development more than a decade ago, brain organoids — brain-like structures grown in petri dishes from human stem cells — have helped scientists better understand a range of neurological disorders, including schizophrenia, epilepsy, and autism spectrum...
Fernando Camargo recognized for pioneering scientific contributions and outstanding leadership
Fernando Camargo, Ph.D., has been named as the inaugural Regenerative Biology Endowed Chair by the Boston Children’s Hospital (BCH) Department of Pediatrics, in recognition of his pioneering scientific contributions and outstanding leadership. Camargo is a professor in the Harvard Department of Stem Cell and Regenerative Biology (HSCRB) and Harvard Medical School (HMS)...
Douglas Melton, Co-Director of the Harvard Stem Cell Institute (HSCI), has received a financial grant from His Highness Sheikh Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi. The grant will bolster HSCI research focusing on accelerating gene editing approaches for pancreatic beta cell replacement therapy.
According to the World Health Organization, about 422 million people worldwide have diabetes, and 1.6 million deaths are directly attributed to diabetes each year. Both the number of cases and the prevalence of diabetes have been steadily increasing over the past few...
AWARD AMOUNT Up to $100,000 for entire project period Project period not to exceed 2 years
POSTED DATE Wednesday, February 2, 2022
DEADLINE FOR APPLICATION Friday, March 4, 2022
ANTICIPATED AWARD DATE April 1, 2022
The Harvard Stem Cell Institute (HSCI) Cancer Program invites applications for pilot grants to be awarded for research in 2022. The intent is to provide resources for innovative projects dissecting stem/developmental programs in solid tumors that would help foster collaborations within the HSCI research community. This funding is for innovative, high-impact research projects. Multi-investigator, multi-institution proposals are encouraged; of specific interest to this funding cycle are proposals that dissect mechanisms that enable malignant stem cells to evade the immune system. Additionally, the applications should promote the Program mission: To identify critical genes and pathways that sufficiently distinguish cancer from normal stem cells and hence may serve as candidate targets for therapy.... Read more about Call for Proposals: 2022 HSCI Cancer Program Pilot Grants